Dr. Litzow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1986 - 1989- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1980 - 1984
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1980
Certifications & Licensure
MN State Medical License 1981 - 2025
MT State Medical License 2013 - 2025
FL State Medical License 2013 - 2024
MI State Medical License 2013 - 2024
IA State Medical License 2013 - 2024
ND State Medical License 2014 - 2024
AZ State Medical License 2013 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
Clinical Trials
- Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission Start of enrollment: 1993 May 07
- Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia Start of enrollment: 2000 Oct 04
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Start of enrollment: 2000 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia.Xin Huang, Yizhen Li, Jingliao Zhang, Lei Yan, Huanbin Zhao, Liang Ding, Sheetal Bhatara, Xu Yang, Satoshi Yoshimura, Wenjian Yang, Seth E Karol, Hiroto Inaba, Charles...> ;Cancer Cell. 2024 Apr 8
- A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia.Guru Subramanian Guru Murthy, Antoine N Saliba, Aniko Szabo, Alexandra Harrington, Sameem Abedin, Karen Carlson, Laura Michaelis, Lyndsey Runaas, Arielle Baim, Alex Hi...> ;Haematologica. 2024 Apr 4
- Building a better blinatumomab.Mark R Litzow> ;American Journal of Hematology. 2024 Apr 1
- Join now to see all
Journal Articles
- Final Results of a Randomized Multicenter Phase II Study of Alvocidib, Cytarabine, and Mitoxantrone Versus Cytarabine and Daunorubicin (7+3) in Newly Diagnosed High-Ri...Joshua F Zeidner, Mark R Litzow, Jeffrey E Lancet, Prithviraj Bose, Raoul Tibes, Ivana Gojo, Richard F Little, Judith E Karp, Leukemia Research
- Does Matching for SNPs in the MHC Gamma Block in 10/10 HLA-Matched Unrelated Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant Improve Outcomes?Eapen K Jacob, Shahrukh K Hashmi, Justin D Kreuter, William J Hogan, Dennis A Gastineau, Ann M Moyer, Mark Litzow, ScienceDirect
Abstracts/Posters
- Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particular...Mark Litzow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- DNA Cytosine-Demethylating Agent 5-Aza-2'-Deoxycytidine Targets Leukemia Cells through Reducing DNA N6-MethyladenineMark Litzow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Response to Erythropoiesis Stimulating Agents in Patients with WHO-Defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytos...Mark Litzow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Special Education Session on ASH Clinical Practice Guidelines on Acute Myeloid Leukemia in Older Adults61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- A Panoply of Immunotherapies for Adult B-Lineage Acute Lymphocytic Leukemia60th American Society of Hematology Annual Meeting - 12/3/2018
- Wide Variation in Use and Interpretation of Gene Mutation Profiling Panels Among Health Care Providers of Patients with Myelodysplastic Syndromes (MDS): Results of a L...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Authored Content
- Final Results of a Randomized Multicenter Phase II Study of Alvocidib, Cytarabine, and Mitoxantrone Versus Cytarabine and Daunorubicin (7+3) in Newly Diagnosed High-Risk Acute Myeloid Leukemia (AML)August 2018
Press Mentions
Trial Suggests Expanded Role for Blinctyo in Treating LeukemiaFebruary 10th, 2023- Blinatumomab-Based Consolidation Deemed New Standard Care for Adults with MRD-Negative B-ALLDecember 16th, 2022
- Blinatumomab Consolidates Its Role in ALLDecember 15th, 2022
- Join now to see all
Grant Support
- Dendritic Cell Therapy Of Chronic Myelogenous LeukemiaNational Cancer Institute2001–2003
- Trial Of Recombinant Interleukin-3 And GM-CSFNational Center For Research Resources1994–1996
Professional Memberships
- Member
Hospital Affiliations
Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
